Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome

E-ISSN： 1365-2141|169|4|461-461

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.4, 2015-05, pp. : 461-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 64-66

Karger

Access to resources Recommend Favorite

Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 273-276

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pyoderma gangrenosum and annular erythema associated with Sjögren's syndrome controlled with minocycline

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 8, 2015-08 ,pp. : 834-836

John Wiley & Sons Inc

Access to resources Recommend Favorite

PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e17-e18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pyoderma Gangrenosum with Systemic Involvement

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 7, 1995-07 ,pp. : 515-519

John Wiley & Sons Inc

Access to resources Recommend Favorite